Cargando…
Pretreatment prognostic factor for patients with human papillomavirus related oropharyngeal cancer
Autores principales: | Sano, Daisuke, Oridate, Nobuhiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798160/ https://www.ncbi.nlm.nih.gov/pubmed/35116767 http://dx.doi.org/10.21037/tcr.2019.04.02 |
Ejemplares similares
-
Pathogenic Role of Immune Evasion and Integration of Human Papillomavirus in Oropharyngeal Cancer
por: Hatano, Takashi, et al.
Publicado: (2021) -
Long-term efficacy of immune checkpoint inhibitors with or without chemotherapy in recurrent or metastatic squamous cell carcinoma of the head and neck: a commentary on the 4-year follow-up of the KEYNOTE-048 trial
por: Sano, Daisuke, et al.
Publicado: (2023) -
The Second-Look Procedure for Transoral Videolaryngoscopic Surgery for T1 and T2 Laryngeal, Oropharyngeal, and Hypopharyngeal Cancer Patients: Protocol for a Nonrandomized Clinical Trial
por: Nishimura, Goshi, et al.
Publicado: (2017) -
A prospective clinical trial of the second‐look procedure for transoral surgery in patients with T1 and T2 laryngeal, oropharyngeal, and hypopharyngeal cancer
por: Nishimura, Goshi, et al.
Publicado: (2019) -
Oropharyngeal Cancer Epidemic and Human Papillomavirus
por: Ramqvist, Torbjörn, et al.
Publicado: (2010)